Editorial: Can Glucagon Like Peptide 1 (GLP1) Agonists or Sodium-Glucose Co-Transporter 2 (SGLT2) Inhibitors Ameliorate Non-Alcoholic Steatohepatitis in People with or without Diabetes? Επικοινωνία Submitted by Δημήτρης Σπάχος on Τρί, 10/02/2018 - 12:48
